ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model

被引:1
|
作者
Kepenekian, Vahan [1 ,2 ]
Sgarbura, Olivia [3 ]
Marchal, Frederic [4 ]
Villeneuve, Laurent [2 ,5 ]
Kusamura, Shigeki [6 ]
Deraco, Marcello [6 ]
机构
[1] Hop Lyon Sud, Serv Chirurg Digest, Hosp Civils Lyon, Pierre Benite, France
[2] Univ Lyon, Univ Claude Bernard Lyon 1, Fac Med Lyon Sud, CICLY, Lyon, France
[3] Univ Montpellier, Montpellier Canc Inst ICM, Surg Oncol Dept, Montpellier, France
[4] Univ Lorraine, Dept Surg Oncol, Inst Cancerol Lorraine, Nancy, France
[5] Hop Lyon Sud, Hosp Civils Lyon, Serv Rech & Epidemiol Clin, Lyon, France
[6] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Peritoneal Malignancy Program, Milan, Italy
关键词
D O I
10.1245/s10434-023-14120-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:7858 / 7859
页数:2
相关论文
共 50 条
  • [1] ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols—Malignant Peritoneal Mesothelioma as a Model
    Vahan Kepenekian
    Olivia Sgarbura
    Frederic Marchal
    Laurent Villeneuve
    Shigeki Kusamura
    Marcello Deraco
    [J]. Annals of Surgical Oncology, 2023, 30 : 7858 - 7859
  • [2] A case report of hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) for malignant peritoneal mesothelioma
    Liu, Hanjian
    Yuan, Chuzhi
    Huang, Yongsheng
    Xu, Ning
    [J]. ASIAN JOURNAL OF SURGERY, 2023, 46 (12) : 5747 - 5748
  • [3] ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma
    Paul H. Sugarbaker
    [J]. Annals of Surgical Oncology, 2021, 28 : 7118 - 7119
  • [4] ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma
    Sugarbaker, Paul H.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7118 - 7119
  • [5] ASO Author Reflections: Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Lee, Z. J.
    Teo, C. C. M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 757 - 758
  • [6] ASO Author Reflections: Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Z. J. Lee
    C. C. M. Teo
    [J]. Annals of Surgical Oncology, 2018, 25 : 757 - 758
  • [7] ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC
    Chatterjee, Ambarish
    Kusamura, Shigeki
    Baratti, Dario
    Guaglio, Marcello
    Battaglia, Luigi
    Deraco, Marcello
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2511 - 2512
  • [8] ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC
    Chatterjee, Ambarish
    Kusamura, Shigeki
    Baratti, Dario
    Guaglio, Marcello
    Battaglia, Luigi
    Deraco, Marcello
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2511 - 2512
  • [9] ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC
    Ambarish Chatterjee
    Shigeki Kusamura
    Dario Baratti
    Marcello Guaglio
    Luigi Battaglia
    Marcello Deraco
    [J]. Annals of Surgical Oncology, 2024, 31 : 2511 - 2512
  • [10] Diffuse Malignant Peritoneal Mesothelioma: Failure Analysis Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    D. Baratti
    S. Kusamura
    A. D. Cabras
    P. Dileo
    B. Laterza
    M. Deraco
    [J]. Annals of Surgical Oncology, 2009, 16 : 463 - 472